Generic medicine
Telmisartan + Hydrochlorothiazide
Telmisartan + Hydrochlorothiazide · Cardiovascular · Angiotensin receptor blockers
Data statusRegistration & price fields require source verification.
108brands/products
31companies
108with current prices
Available dosage forms
Tap a form to filter the brand listChoose a form
Pakistan brand index
Available brands
| Brand | Manufacturer | Strength | Form | Pack | Reg. no. | Official price | Unit price |
|---|---|---|---|---|---|---|---|
| Co-Telnip | The Searle Company Limited | 80 mg + 25 mg | Tablet | 28's | 103258 | PKR 2,377.992026-07-23 | PKR 84.93/ tablet |
| Co-Telnip + | The Searle Company Limited | 80 mg + 25 mg | Tablet | 14's | 103258 | PKR 1,258.322026-07-23 | PKR 89.88/ tablet |
| Co-Telnip + | The Searle Company Limited | 40 mg + 12.5 mg | Tablet | 14's | 103256 | PKR 661.152026-07-23 | PKR 47.23/ tablet |
| Co-Telnip + | The Searle Company Limited | 80 mg + 12.5 mg | Tablet | 14's | 103257 | PKR 1,247.652026-07-23 | PKR 89.12/ tablet |
| CO-TELSAN 40 | Hilton Pharma (Pvt) Limited. | 12.5 mg + 12.5 mg | Tablet | 14's | 047124 | PKR 706.622026-07-22 | PKR 50.47/ tablet |
| CO-TELSAN 80 | Hilton Pharma (Pvt) Limited. | 12.5 mg + 12.5 mg | Tablet | 14's | 047125 | PKR 1,333.482026-07-22 | PKR 95.25/ tablet |
| CO-TIOCARDIS | Atco Laboratories Limited | 80 mg + 12.5 mg | Tablet | 28's | 098769 | PKR 2,049.712026-07-23 | PKR 73.20/ tablet |
| CO-TIOCARDIS | Atco Laboratories Limited | 40 mg + 12.5 mg | Tablet | 14's | 098768 | PKR 572.452026-07-23 | PKR 40.89/ tablet |
| CO-TIOCARDIS | Atco Laboratories Limited | 25 mg + 80 mg | Tablet | 14's | 098770 | PKR 1,089.502026-07-23 | PKR 77.82/ tablet |
| CO-TIOCARDIS | Atco Laboratories Limited | 40 mg + 12.5 mg | Tablet | 28's | 098768 | PKR 1,087.632026-07-23 | PKR 38.84/ tablet |
| CO-TIOCARDIS | Atco Laboratories Limited | 80 mg + 12.5 mg | Tablet | 14's | 098769 | PKR 1,080.242026-07-23 | PKR 77.16/ tablet |
| CRESAR-H | TABROS PHARMA (PVT). LTD. | 40 mg + 12.5 mg | Tablet | 28's | 055903 | PKR 1,216.302026-07-27 | PKR 43.44/ tablet |
| CRESAR-H | TABROS PHARMA (PVT). LTD. | 80 mg + 12.5 mg | Tablet | 28's | 055904 | PKR 2,292.262026-07-27 | PKR 81.87/ tablet |
| CRESAR-H 40 | TABROS PHARMA (PVT). LTD. | 40 mg + 12.5 mg | Tablet | 14's | 055903 | PKR 640.162026-07-27 | PKR 45.73/ tablet |
| CRESAR-H 80 | TABROS PHARMA (PVT). LTD. | 80 mg + 12.5 mg | Tablet | 14's | 055904 | PKR 1,208.042026-07-27 | PKR 86.29/ tablet |
| CRESAR-H 80 | TABROS PHARMA (PVT). LTD. | 80 mg + 25 mg | Tablet | 14's | 055905 | PKR 1,218.372026-07-27 | PKR 87.03/ tablet |
| De-Nile Plus | Mass Pharma (Pvt) Ltd. | 20 mg + 12.5 mg | Tablet | 1x10 | 063148 | PKR 261.752025-09-05 | PKR 26.18/ tablet |
| De-Nile Plus | Mass Pharma (Pvt) Ltd. | 80 mg + 12.5 mg | Tablet | 2x7 | 060306 | PKR 1,151.332025-09-05 | PKR 82.24/ tablet |
| De-Nile Plus | Mass Pharma (Pvt) Ltd. | 40 mg + 12.5 mg | Tablet | 2x7 | 060305 | PKR 610.112025-09-05 | PKR 43.58/ tablet |
| Mested | Genome Pharmaceuticals (Pvt.) Ltd, | 40 mg + 12.50 mg | Tablet | 14's | 101415 | PKR 572.442026-07-27 | PKR 40.89/ tablet |
Independent editorial layer
Medicine information
Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.